Abstract | OBJECTIVES: DESIGN: An open-label prospective study. SETTING: Academic medical center. PATIENTS: INTERVENTION: MAIN OUTCOME MEASURE: Scores from the Sino-Nasal Outcome Test-20 (SNOT-20), a tool for assessing rhinosinusitis health and quality of life, were used to assess efficacy of budesonide treatment. RESULTS: All of our patients showed adequate adrenal response to cosyntropin stimulation before and after the budesonide trial. The mean difference in SNOT-20 scores was -1 (95% confidence interval, -1.77 to -0.23; P = .02), indicating clinically significant improvement after therapy. CONCLUSION: Our findings suggest that using budesonide nasal wash may be clinically effective in decreasing the symptoms of chronic rhinosinusitis and does so without suppression of the hypothalamic-pituitary-adrenal axis in patients with chronic rhinosinusitis.
|
Authors | Neil S Sachanandani, Jay F Piccirillo, Maggie A Kramper, Stanley E Thawley, Anna Vlahiotis |
Journal | Archives of otolaryngology--head & neck surgery
(Arch Otolaryngol Head Neck Surg)
Vol. 135
Issue 3
Pg. 303-7
(Mar 2009)
ISSN: 1538-361X [Electronic] United States |
PMID | 19289711
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
|
Chemical References |
- Glucocorticoids
- Budesonide
- Hydrocortisone
|
Topics |
- Administration, Intranasal
- Adolescent
- Adrenal Cortex
(drug effects, metabolism)
- Adult
- Aged
- Budesonide
(administration & dosage)
- Chronic Disease
- Dose-Response Relationship, Drug
- Female
- Follow-Up Studies
- Glucocorticoids
(administration & dosage)
- Humans
- Hydrocortisone
(blood)
- Immunoassay
- Male
- Middle Aged
- Patient Satisfaction
- Prospective Studies
- Rhinitis
(blood, complications, drug therapy)
- Sinusitis
(blood, complications, drug therapy)
- Surveys and Questionnaires
- Treatment Outcome
- Young Adult
|